DEVELOPMENT OF A NOVEL ZIRCONIUM-89 LABELLED ANTIBODY FOR IMAGING PD-L1 DYNAMICS IN MICE MESOTHELIOMA

被引：0
|
作者：
Mohamed, Shifaza [1 ]
机构：
[1] Sir Charles Gairdner Hosp, Nedlands, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [41] Development of an Anti-canine PD-L1 Antibody and Caninized PD-L1 Mouse Model as Translational Research Tools for the Study of Immunotherapy in Humans
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Dhawan, Deepika
    Kirkham, Perry M.
    Ostafe, Raluca
    Franco, Jackeline
    Aryal, Uma K.
    Carnahan, Robert H.
    Patsekin, Valery
    Robinson, J. Paul
    Knapp, Deborah W.
    Lim, Seung-Oe
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (05): : 860 - 873
  • [42] PET imaging of radiation-induced PD-L1 upregulation in the tumor microenvironment using a Zr-89 labeled PD-L1 monoclonal Ab in a mouse model
    Kikuchi, Masahiro
    Srivastava, Raghvendra
    Sun, Lingyi
    Zeng, Dexing
    Diaz-Perez, Julio
    Anderson, Carolyn
    Ferris, Robert
    Edwards, W. Barry
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [43] Mapping the epitope of PD-L1 to the paratope of the antibody durvalumab using molecular dynamics simulation
    Tu, Wenjian
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (01): : 85 - 97
  • [44] PET imaging of the PD-1/PD-L1 checkpoint in naive and irradiated tumor-bearing mice
    Hettich, M.
    Braun, F.
    Niedermann, G.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S93 - S93
  • [45] PET imaging of PD-L1 using anti-PD-L1-B11 antibody in breast cancer tumor model
    Bansal, Aditya
    Barham, Whitney
    Liu, Xin
    Harrington, Susan
    Lucien-Matteoni, Fabrice
    Dong, Haidong
    Park, Sean
    Pandey, Mukesh
    DeGrado, Timothy
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [46] Dose-dependent targeting of 89Zr-labeled atezolizumab (anti-PD-L1 antibody) to PD-L1 expressing tumor xenografts
    Longtine, Mark
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [47] Development of a diagnostic antibody for anti-BTN1A1 therapy, a novel immune checkpoint inhibitor mutually exclusive of PD-L1/PD-1
    Yoo, Stephen S.
    CANCER RESEARCH, 2023, 83 (07)
  • [48] [99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression
    Nazir, Muhummad Sohaib
    Hughes, Daniel Johnathan
    Chand, Gitasha
    Adamson, Kathryn
    Johnson, Jessica
    Bailey, Damion
    Gibson, Victoria
    Ting, Hong Hoi
    Lyon, Alexander
    Cook, Gary J. R.
    EJNMMI RESEARCH, 2023, 13 (01)
  • [49] [99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression
    Muhummad Sohaib Nazir
    Daniel Johnathan Hughes
    Gitasha Chand
    Kathryn Adamson
    Jessica Johnson
    Damion Bailey
    Victoria Gibson
    Hong Hoi Ting
    Alexander R. Lyon
    Gary J. R. Cook
    EJNMMI Research, 13
  • [50] Development of a canine PD-L1 antibody and caninized PD-L1 mouse model: an essential translational research tool to raise the success rate of immunotherapy in humans
    Oh, Wonkyung
    Kim, Alyssa
    Dhawan, Deepika
    Kirkham, Perry M.
    Knapp, Deborah W.
    Lim, Seung-Oe
    CANCER RESEARCH, 2023, 83 (07)
12345